Zobrazeno 1 - 2
of 2
pro vyhledávání: '"S. E. Auteri"'
Autor:
Elisabetta Botti, Roberta Pica, Alessia Butera, Carlo Chizzolini, Michel Gilliet, Raffaella Palazzo, Antonio Costanzo, K. Giannakakis, F. Stuber, Francesca Romana Spinelli, Valeria Riccieri, Laurence Feldmeyer, Luca Bianchi, Camilla Jandus, Francesca Spadaro, Eddie A. James, I. Daniels, Barbara Marinari, G. Valesini, L. G. Durrant, Fabrizio Conti, J. Di Lucca, Bruna Cerbelli, Cristiano Alessandri, Loredana Frasca, Roberto Lande, Pedro Romero, Monica Boirivant, Nicolas Gestermann, Mario Falchi, S. E. Auteri, S. Horstman, Isabelle Surbeck
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-14 (2020)
Scientific Reports, Vol. 10, No 1 (2020) P. 5851
Scientific Reports
Scientific reports, vol. 10, no. 1, pp. 5851
Scientific Reports, Vol. 10, No 1 (2020) P. 5851
Scientific Reports
Scientific reports, vol. 10, no. 1, pp. 5851
LL37 exerts a dual pathogenic role in psoriasis. Bound to self-DNA/RNA, LL37 licenses autoreactivity by stimulating plasmacytoid dendritic cells-(pDCs)-Type I interferon (IFN-I) and acts as autoantigen for pathogenic Th17-cells. In systemic lupus ery
Autor:
G. Valesini, Roberto Lande, Cesare Alessandri, Stefano Alivernini, Maria Sole Chimenti, Loredana Frasca, Fabrizio Conti, Tania Colasanti, Elisa Gremese, Luca Bianchi, E. Botti, Giulia Lavinia Fonti, Barbara Tolusso, Barbara Marinari, F.R. Spinelli, Immacolata Pietraforte, S. E. Auteri, Roberto Perricone, Francesca Spadaro, Antonio Costanzo, Raffaella Palazzo
Publikováno v:
Saturday, 16 JUNE 2018.
Background The antimicrobial peptide LL37 plays a pathogenic role in psoriasis (Pso) due to its adjuvant and auto-antigenic properties. At least a third of Pso patients develop psoriatic arthritis (PsA) but mechanisms that lead PsA development in Pso